Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Save to My Library
Look up keyword
Like this
3Activity
0 of .
Results for:
No results containing your search query
P. 1
U.S. v. Pfizer HCP Corporation (Information)

U.S. v. Pfizer HCP Corporation (Information)

Ratings: (0)|Views: 206 |Likes:
Published by Mike Koehler

More info:

Published by: Mike Koehler on Aug 08, 2012
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PDF, TXT or read online from Scribd
See more
See less

06/28/2014

pdf

text

original

 
iTNITED
STATES
ISTRICT
COURT
FOR THE
ISTRICT
OF
OLUMBIA
UNITEI3
STATES
OF
AMERICA,
Plaintiff,
v.
PFIZER
.C.P.
CORPORATION,
Defendant.Criminal
No.
VIOLATIONS:
Count
:
18
U.S.C.
§
71
(Conspiracy)
Count
:
15
U.S.C.
§
8dd
-2(a)
(FCPA
nti-briberyViolation)
INFORMATION
The
nited
States
Department
of
ustice,
Criminal
Division,
Fraud
ection,
charges
asfollows:
GENERAL
ALLEGATIONS
At
ll
times
material
to
this
Information
unless
specified
otherwise):
TIZe
Foreign CoYrupt
ractices
Act
1.
The
oreign
Corrupt
ractices
Act
of
-1977
r~ereinafter
the
"FCPA
"),
as
amended,
Title
15,
United
States
Code,
ections
78dd
-1
et
eq.,
prohibitedcertain
classes
of
ersons
and
entities
from
orruptly
making
payments
o foreign
government
fficials
to
assist
in
obtaining
or
retainingbusiness.
Furthermore,
he
FCPA
equired
issuers
to
make
and
keepbooks,
ecords,
and
ccounts
thataccurately
and
airly
reflected
transactions
and
disposition
of
he
company's
assets
and
rohibited
the
knowing
alsification
of
n
ssuer's
books,
ecords, or
accounts.
Isu.s.c.
§
sm~v)(2)(A).
Relevant
ntities
and
ndividuals
2.
The
efendant,
PFIZER
.C.P.
CORPORATION
(
PFIZER
HCP
"),
was
an
indirect
wholly
owned
ubsidiary
of
fizer
Inc_
(
Pfizer
")
nd
was
ncorporated
under
he
laws
 
of
he-
State
of
New
ork.
PFIZER
HCP
as
a
domestic concern"
ithinthe
meaning
of
he
FCPA,
5
U.S.C:78~d-
2(h)(1).
PFIZER
CP's
ndirect
parent
company,
fizer,
was
a
lobalpharmaceutical,
animal
ealth,
and
consumer
roduct
company
eadquartered
in
New
ork,
New
ork,
and
ncorporated
-
in
Delaware.
It
issued
and
maintained
a
lass
of
ubliclytraded
securitiesregistered
pursuantto
Section
12(b)
of
he
Securities
Exchange
Act,
and
ts
common
stocktraded
on
he
New
ork
Stock
Exchange
under
he,
symbol
PFE_"
As
uch,
fizer
was
required
to
file
periodicreports
with
the
United
StatesSecurities
and
Exchange
Commission
the
"Commission
")
nder
Section
13
of
he
Securities
Exchange
Act.
Accordingly,
Pfizer
was
an
"issuer"withinthe
meaning
of
he
FCPA,
5
U.S.C.
§
78dd
-1(a).
During
he
relevant
period,
PFIZER
HCP
peratedin
several
international
markets
through
epresentativeoffices,
including
offices
in
Bulgaria,
Croatia,
and
Kazakhstan,
s
wellas
through
ontracts
with
Russian
distributors
and
employees
of
a
epresentative
office
of
FIZER
HCP's
arent
company
n
Moscow
(
Pfizer
Russia
").
The
books
and
ecords
of
FIZER
HCP,
hich
ncluded
revenues
from
theaforementioned
countries,
were
onsolidated
into
the
booksand
ecords
of
fizerfor
the
purposes
of
reparing
Pfizer's
year
-end
inancial
statements,
which
were
iled
with
he
Commission
n
Washington,
.C.
3.
Croatian
Official,
a
itizen
of
he
Republic
of
roatia,
held
official
positions
on
government
committees
nCroatia
and
had
nfluence
over
ecisions
concerning
the
egistration
andreimbursement
of
fizer
products
marketed
and
old
in
thecountry. Croatian
Official
was
a
"foreign
official"
as
that
term
is
defined
in
the
FCPA,
5
U.S.C.
§
78dd-
2(h)(2).4_
Kazakh
Company
was
aKazakh
company
hatcontracted
with
PFIZER
HCP
o
provide
distribution
services
and
elated
services
inthe
Republic
of
azakhstan.
In
ight
of
heforegoing,
Kazakh
Company
was
an
"agent
of
domestic
oncern,"
as
that
term
is
defined
in
the
FCPA,
5
U.S.C.
§
78dd-
2(h)(1).
 
5.Russian
Official
1,
a
itizen
of
he
Russian
Federation,
was
a
medical
octor,
employed
by
a
ublic
hospital,
and had
nfluence
over
the
Russiangovernment'spurchase
and
prescription
of
fizer
products
marketed
and
old
in
thecountry.
Russian
Official
1
was
a
"foreign
official"
as
that
term
is
defined
in
the
FCPA,
5U.S.C.
§
78dd-
2(h)(Z).
6.
Russian
Official
2,
a
itizen
of
he
Russian
Federation,
was
ahigh-
ranking
government
fficial,
who
eld
official
positions
on
government
committees
n
Russia,
and
had
influence
over
decisions
concerning
the
reimbursement
of
fizer
products
marketed
and
soldin
the
country.
Russian
Official2
was
a
foreign
official"
as
that
term
s
defined
in
the
FCPA,
5U.S.C.
§
8dd-
2(h)(2).
7.Russian
Official
3,
a
itizen
of
he
Russian
Federation,
had
nfluence
over
decisions
concerning
the
treatment
algorithmsinvolving
Pfizer
products
marketed
and
sold
in
thecountry.
Russian
fficial
3
as a
foreign
official"
as
that
term
is
defined
in
the
FCPA,
5
U.S.C.
§
78dd-
2(h)(2).
8.
Russian
Company
was
a
ussian
company
hat
bid
on
enders issued
by
ussian
healthcare
institutions
and
worked
with
PFIZER
HCP
nd
fizer
Russia
to
fill
tenders
using
Pfizer
products. In
light
of
he
foregoing,
Russian
Company
was
an
agent
of
domestic
concern,"
as
that
term
s
defined
in
the
FCPA,
5
U.S.C.
§
78dd-
2(h)(1).
9.
Russian
Company
2
as
a
ussian
company
hat
provided
certain
services
to
PFIZER
HCP
nd
fizer
Russia,
including
making
mproper
payments
o
Russian
government
officials
and
ther
companies
on
PFIZER
HCP's
ehalf,in
order to
conceal
the
payments.
In
light
of
he foregoing,
Russian
Company
2
as
an
agent
of
omestic
concern," as
that
term
s
defined
in
the
FCPA,
5 U.S.C.
§
78dd-
2(h)(1).

Activity (3)

You've already reviewed this. Edit your review.
1 thousand reads
1 hundred reads
Mike Koehler liked this

You're Reading a Free Preview

Download
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->